BB Good human data, but mixed outcomes or surrogate markers. How we grade →RCT · 115 healthy adults
Determinants of Erythrocyte Omega-3 Fatty Acid Content in Response to Fish Oil Supplementation: A Dose-Response Randomized Controlled Trial
M Flock, A Skulas-Ray, W Harris, T Etherton, J Fleming, P Kris-Etherton. Journal of the American Heart Association. 2013.
- In plain language
- The Omega-3 Index rose with EPA plus DHA dose (0 to 1,800 mg a day, about 5 months); dose per kg of body weight explained 70% of the response.
- Limits
- Measures a blood marker, not health outcomes; small groups per dose.
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: The Omega-3 Index: what it measures, how supplements move it, and what it does and does not predict
- AA Multiple randomized trials or meta-analyses, consistent results. How we grade →Graded claim: Omega-3 (EPA and DHA): EPA and DHA status
- Source
- doi.org/10.1161/JAHA.113.000513 · PubMed 24252845 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.